TRIMEPRAZINE TARTRATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for trimeprazine tartrate and what is the scope of freedom to operate?
Trimeprazine tartrate
is the generic ingredient in two branded drugs marketed by Allergan Herbert, Alpharma Us Pharms, and Morton Grove, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for trimeprazine tartrate.
Summary for TRIMEPRAZINE TARTRATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 229 |
| DailyMed Link: | TRIMEPRAZINE TARTRATE at DailyMed |
Medical Subject Heading (MeSH) Categories for TRIMEPRAZINE TARTRATE
US Patents and Regulatory Information for TRIMEPRAZINE TARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morton Grove | TRIMEPRAZINE TARTRATE | trimeprazine tartrate | SYRUP;ORAL | 088285-001 | Apr 11, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan Herbert | TEMARIL | trimeprazine tartrate | SYRUP;ORAL | 011316-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | TRIMEPRAZINE TARTRATE | trimeprazine tartrate | SYRUP;ORAL | 085015-001 | Feb 18, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan Herbert | TEMARIL | trimeprazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 011316-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan Herbert | TEMARIL | trimeprazine tartrate | TABLET;ORAL | 011316-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
